InterCure Begins 2022 with Record Breaking First Quarter Financial Results Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million...
InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1) Fourth quarter 2021 Revenue and Adjusted EBITDA2 of $33 million and $9 million, representing an increase of almost 200% and...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better” Marking the First Major Consolidation in Pharmaceutical Grade Medical Cannabis Market Acquisition is Expected to be Accretive Strengthen...
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue – 3 Times YoY and 24% QoQ Growth Estimated revenue reaches over CAD$31 million (a record NIS 77 million) Anticipates continued...
The Global Cannabis Stock Index fell for the ninth consecutive month, declining 9.6% to 37.13: The index, which was down 21.2% in Q3, had 42 qualifying members during the month and is...
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This data-driven, fact-based tracker will continually update based on new financial...
InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth Seventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run...
InterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million – 3 Times YOY and 36% QOQ Growth Achieved a number of firsts and records including: Seventh consecutive quarter...
The Global Cannabis Stock Index fell for the seventh consecutive month, declining 12.6% to 45.02: The index, which was down 21.2% in Q3, had 44 qualifying members during the month following the...
Subversive Acquisition LP Announces InterCure’s Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd....
Subversive Announces Qualifying Transaction with InterCure, Israel’s Leading and Fastest-Growing Cannabis Company Combined Company will be led by Chairman and Former Prime Minister of Israel Ehud Barak and...
Charlotte’s Web Expands into Israel Through Strategic Alliance with InterCure, Owner of Canndoc Agreement with Israeli medical cannabis leader is one of Charlotte’s Web’s largest international collaborations BOULDER, Colo....
MONCTON, New Brunswick, August 14, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis,...
